<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-niacin.xml</id>
  <title>Recalls Watch: Niacin</title>
  <link rel="self" href="https://recalls.watch/feed/substance-niacin.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-06-17T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/99127/</id>
    <title>Golden State Medical Supply Inc.: GSMS Incorporated</title>
    <link href="https://recalls.watch/recall/fda/99127/"/>
    <updated>2026-06-17T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/99107/</id>
    <title>Lannett Company Inc.: Niacin Extended-release Tablets</title>
    <link href="https://recalls.watch/recall/fda/99107/"/>
    <updated>2026-06-10T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97859/</id>
    <title>Golden State Medical Supply Inc.: NIACIN Extended-Release Tablets</title>
    <link href="https://recalls.watch/recall/fda/97859/"/>
    <updated>2025-11-26T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Dissolution Specifications</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97778/</id>
    <title>Lannett Company Inc.: Niacin Extended-release Tablets</title>
    <link href="https://recalls.watch/recall/fda/97778/"/>
    <updated>2025-10-29T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Dissolution Specifications</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/93820/</id>
    <title>SUN PHARMACEUTICAL INDUSTRIES INC: Cinacalcet Tablets 60mg and 10 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=93820"/>
    <updated>2024-01-31T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.</summary>
  </entry>
</feed>
